Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc. (NATR)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: A global natural health and wellness company manufacturing and direct-selling nutritional and personal care products through a network of independent consultants. Operations are segmented into Asia, Europe, North America, and Latin America & Other.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Net Sales | $480.1 million | $454.4 million |
| Gross Profit | $347.7 million | $324.7 million |
| Gross Margin | 72.4% | 71.5% |
| Operating Income | $24.7 million | $20.1 million |
| Net Income (Attributable to Common Shareholders) | $19.5 million | $7.7 million |
| Diluted EPS | $1.06 | $0.40 |
| Operating Cash Flow | $35.3 million | $25.3 million |
| Cash and Cash Equivalents | $93.9 million | $84.7 million |
| Working Capital | $100.3 million | $94.9 million |
| Debt | $0 (No outstanding balance on revolving credit facility) | $0 |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net sales increased 5.7% ($25.8 million) year-over-year. Excluding foreign currency impacts, sales grew 5.3%.
- Asia: Sales up 6.7% (driven by strong performance in Japan and China).
- Europe: Sales up 9.8% (driven by improved customer acquisition).
- North America: Sales up 3.4% (driven by digital channel growth and subscriptions).
- Latin America & Other: Sales down 5.5%.
- Profitability: Net income attributable to common shareholders more than doubled to $19.5 million from $7.7 million. The effective tax rate decreased significantly from 57.2% in 2024 to 31.4% in 2025, primarily due to the expiration of foreign tax credits in the prior period and reduced valuation allowances.
- Expenses: Selling, general, and administrative (SG&A) expenses increased $14.4 million (to 37.2% of sales) due to timing of compensation costs, digital marketing investments, and increased service fees in China. Cost of sales as a percentage of net sales improved to 27.6% from 28.5%.
- Foreign Exchange: A strengthening U.S. dollar provided a favorable impact of approximately $1.8 million to reported net sales.
Guidance, Outlook, Risks, and Unusual Items
- China Acquisition: On December 17, 2025, the Company completed the purchase of the remaining interests in its China joint ventures (Nature's Sunshine Hong Kong Limited and Shanghai Nature's Sunshine Health Products) from Fosun Industrial. Total consideration was $7.0 million ($6.0 million paid at closing, $1.0 million deferred to 2027). This transition introduces integration and compliance risks associated with direct ownership in China.
- Regulatory Investigations: The Company voluntarily self-disclosed potential trade controls violations to the U.S. Department of Commerce (BIS) and OFAC in 2025. The violations represented less than 1% of net revenue. While management believes potential fines are not material, the outcome remains uncertain.
- Geopolitical Risks: Ongoing conflict in Russia and Ukraine continues to impact operations in the Eastern Europe segment, though sales in the region increased to $60.0 million in 2025.
- Tariffs: Management expects tariffs to adversely affect costs in 2026, though no material impact was experienced in 2025.
- Capital Allocation: The Company repurchased 1.26 million shares for $16.3 million in 2025. $17.4 million remains available under the current repurchase program.
Investor Verification Checklist
- China Integration: Verify the operational and financial impact of the full acquisition of China joint ventures and the management of the $1.0 million deferred payment obligation due in 2027.
- Regulatory Resolution: Monitor the status and potential financial penalties resulting from the voluntary self-disclosures to BIS and OFAC regarding trade controls.
- Tax Rate Sustainability: Assess whether the 31.4% effective tax rate in 2025 is sustainable, given the one-time benefit from the expiration of foreign tax credits in 2024.
- Currency Sensitivity: Review the sensitivity analysis indicating that a 10% strengthening of the U.S. dollar could reduce operating income by approximately 20.7%.
- Consultant Retention: Evaluate the impact of high turnover rates among independent consultants on future revenue stability, particularly in key markets like Japan and China.